{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:42Z","timestamp":1790742042991,"version":"4.1.0"},"reference-count":146,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>With the advancement of tumour-targeted therapy technology, the survival of cancer patients has continued to increase, and cardiovascular events have gradually become an important cause of death in cancer patients. This phenomenon occurs due to adverse cardiovascular reactions caused by the cardiovascular toxicity of antitumour therapy. Moreover, the increase in the proportion of elderly patients with cancer and cardiovascular diseases is due to the extension of life expectancy. Hypertension is the most common cardiovascular side effect of small molecule tyrosine kinase inhibitors (TKIs). The increase in blood pressure induced by TKIs and subsequent cardiovascular complications and events affect the survival and quality of life of patients and partly offset the benefits of antitumour therapy. Many studies have confirmed that in the pathogenesis of hypertension, arterioles and capillary thinness are involved in its occurrence and development. Our previous findings showing that apatinib causes microcirculation rarefaction of the superior mesenteric artery and impaired microvascular growth may inspire new therapeutic strategies for treating hypertension. Thus, by restoring microvascular development and branching patterns, total peripheral resistance and blood pressure are reduced. Therefore, exploring the key molecular targets of TKIs that inhibit the expression of angiogenic factors and elucidating the specific molecular mechanism involved are key scientific avenues for effectively promoting endothelial cell angiogenesis and achieving accurate repair of microcirculation injury in hypertension patients.<\/jats:p>","DOI":"10.3389\/fphar.2024.1346905","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:25:01Z","timestamp":1707488701000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Microvascular rarefaction caused by the NOTCH signaling pathway is a key cause of TKI-apatinib-induced hypertension and cardiac damage"],"prefix":"10.3389","volume":"15","author":[{"given":"WenJuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guodong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00003495-200363991-00003","article-title":"Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy","volume":"63","author":"Agabiti-Rosei","year":"2003","journal-title":"Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/CIRCRESAHA.123.323119","article-title":"Myeloid cell derived IL1\u03b2 contributes to pulmonary hypertension in HFpEF","volume":"133","author":"Agrawal","year":"2023","journal-title":"Circ. Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/heart.89.2.175","article-title":"Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension","volume":"89","author":"Antonios","year":"2003","journal-title":"Heart"},{"key":"B4","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3390\/cells10020473","article-title":"Regulation of mitochondrial homeostasis by sAC-derived cAMP pool: basic and translational aspects","volume":"10","author":"Aslam","year":"2021","journal-title":"Cells"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2009.03.025","article-title":"The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis","volume":"137","author":"Benedito","year":"2009","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s10735-020-09940-2","article-title":"Influence of VEGF-A, VEGFR-1-3, and neuropilin 1-2 on progression-free: and overall survival in WHO grade II and III meningioma patients","volume":"52","author":"Bernatz","year":"2021","journal-title":"J. Mol. Histol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"H83","DOI":"10.1152\/ajpheart.1991.261.1.H83","article-title":"Pressure-independent arteriolar rarefaction in hypertension","volume":"261","author":"Boegehold","year":"1991","journal-title":"Am. J. Physiol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s40292-017-0245-9","article-title":"Essential hypertension and functional microvascular ageing","volume":"25","author":"Bruno","year":"2018","journal-title":"High. Blood Press Cardiovasc Prev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/cvr\/cvaa023","article-title":"Coronary microvascular dysfunction in hypertrophy and heart failure","volume":"116","author":"Camici","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e004408","DOI":"10.1161\/CIRCHEARTFAILURE.117.004408","article-title":"Longitudinal assessment of vascular function with sunitinib in patients with metastatic renal cell carcinoma","volume":"11","author":"Catino","year":"2018","journal-title":"Circ. Heart Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1161\/CIRCINTERVENTIONS.110.951277","article-title":"Renal microvascular disease determines the responses to revascularization in experimental renovascular disease","volume":"3","author":"Chade","year":"2010","journal-title":"Circ. Cardiovasc Interv."},{"key":"B13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.devcel.2009.07.011","article-title":"Local guidance of emerging vessel sprouts requires soluble Flt-1","volume":"17","author":"Chappell","year":"2009","journal-title":"Dev. Cell"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1097\/00004872-200312000-00018","article-title":"Capillary rarefaction and abnormal cardiovascular reactivity in hypertension","volume":"21","author":"Ciuffetti","year":"2003","journal-title":"J. Hypertens."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/HYP.0000000000000224","article-title":"Cancer therapy-related hypertension: a scientific statement from the American heart association","volume":"80","author":"Cohen","year":"2023","journal-title":"Hypertension"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.3390\/biomedicines10123150","article-title":"Endothelial damage and the microcirculation in critical illness","volume":"10","author":"Cusack","year":"2022","journal-title":"Biomedicines"},{"key":"B17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4161\/viru.26482","article-title":"Pathophysiology of microcirculatory dysfunction and the pathogenesis of septic shock","volume":"5","author":"De Backer","year":"2014","journal-title":"Virulence"},{"key":"B18","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/HYPERTENSIONAHA.122.19465","article-title":"Microcirculation and physical exercise in hypertension","volume":"80","author":"De Ciuceis","year":"2023","journal-title":"Hypertension"},{"key":"B19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s11906-023-01272-2","article-title":"Microvascular dysfunction in obesity-hypertension","volume":"25","author":"Do","year":"2023","journal-title":"Curr. Hypertens. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s11864-023-01094-z","article-title":"The intersection of prostate cancer and hypertension: a call to action","volume":"24","author":"Dolmatova","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1002\/hep.32332","article-title":"Notch-triggered maladaptation of liver sinusoidal endothelium aggravates nonalcoholic steatohepatitis through endothelial nitric oxide synthase","volume":"76","author":"Fang","year":"2022","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1161\/CIRCRESAHA.116.309859","article-title":"Multifunctional mitochondrial Epac1 controls myocardial cell death","volume":"120","author":"Fazal","year":"2017","journal-title":"Circ. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1093\/cvr\/cvn022","article-title":"Hypertension and microvascular remodelling","volume":"78","author":"Feihl","year":"2008","journal-title":"Cardiovasc Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijcard.2014.03.173","article-title":"Alteration of Notch signaling and functionality of adipose tissue derived mesenchymal stem cells in heart failure","volume":"174","author":"Fortini","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/mt.2015.28","article-title":"cAMP and EPAC signaling functionally replace OCT4 during induced pluripotent stem cell reprogramming","volume":"23","author":"Fritz","year":"2015","journal-title":"Mol. Ther."},{"key":"B26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00018-016-2336-5","article-title":"The role of Epac in the heart","volume":"74","author":"Fujita","year":"2017","journal-title":"Cell Mol. Life Sci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/jcmm.17695","article-title":"Proteomic profiling of epicardial fat in heart failure with preserved versus reduced and mildly reduced ejection fraction","volume":"27","author":"Gao","year":"2023","journal-title":"J. Cell Mol. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1007\/s10554-021-02279-z","article-title":"Cardiovascular magnetic resonance predicts all-cause mortality in pulmonary hypertension associated with heart failure with preserved ejection fraction","volume":"37","author":"Garg","year":"2021","journal-title":"Int. J. Cardiovasc Imaging"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1002\/hep.28245","article-title":"Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice","volume":"63","author":"Gariani","year":"2016","journal-title":"Hepatology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1083\/jcb.200302047","article-title":"VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia","volume":"161","author":"Gerhardt","year":"2003","journal-title":"J. Cell Biol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1136\/heartjnl-2021-319605","article-title":"Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management","volume":"108","author":"Gevaert","year":"2022","journal-title":"Heart"},{"key":"B32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/cells10030521","article-title":"Notch signaling regulation in HCC: from hepatitis virus to non-coding RNAs","volume":"10","author":"Giovannini","year":"2021","journal-title":"Cells"},{"key":"B33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3390\/jcdd8100125","article-title":"Bioengineering systems for modulating notch signaling in cardiovascular development, disease, and regeneration","volume":"8","author":"Gomez","year":"2021","journal-title":"J. Cardiovasc Dev. Dis."},{"key":"B34","first-page":"26","article-title":"Fractal dimensions of skin microcirculation flow in subjects with familial predisposition or newly diagnosed hypertension","volume":"18","author":"Gryglewska","year":"2011","journal-title":"Cardiol. J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"101955","DOI":"10.1016\/j.arr.2023.101955","article-title":"Mitochondrial dysfunction in aging","volume":"88","author":"Guo","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nrm3176","article-title":"Molecular control of endothelial cell behaviour during blood vessel morphogenesis","volume":"12","author":"Herbert","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1210\/endrev\/bnaa025","article-title":"Microvascular dysfunction in diabetes mellitus and cardiometabolic disease","volume":"42","author":"Horton","year":"2021","journal-title":"Endocr. Rev."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/stem.2582","article-title":"NOTCH1-Dependent nitric oxide signaling deficiency in hypoplastic left heart syndrome revealed through patient-specific phenotypes detected in bioengineered cardiogenesis","volume":"35","author":"Hrstka","year":"2017","journal-title":"Stem Cells"},{"key":"B39","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41392-023-01478-5","article-title":"BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"key":"B40","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1093\/eurheartj\/ehab499","article-title":"Sacubitril-valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction","volume":"42","author":"Jackson","year":"2021","journal-title":"Eur. Heart J."},{"key":"B41","doi-asserted-by":"publisher","first-page":"H1344","DOI":"10.1152\/ajpheart.00413.2007","article-title":"Aging enhances pressure-induced arterial superoxide formation","volume":"293","author":"Jacobson","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/jnr.24477","article-title":"Soluble adenylyl cyclase-mediated cAMP signaling and the putative role of PKA and EPAC in cerebral mitochondrial function","volume":"97","author":"Jakobsen","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/ncb2103","article-title":"Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting","volume":"12","author":"Jakobsson","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"4945","DOI":"10.1007\/s00018-019-03152-y","article-title":"Regulation of AMPK activity by type 10 adenylyl cyclase: contribution to the mitochondrial biology, cellular redox and energy homeostasis","volume":"76","author":"Jayarajan","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e39093","DOI":"10.1371\/journal.pone.0039093","article-title":"Dissecting and circumventing the requirement for RAM in CSL-dependent Notch signaling","volume":"7","author":"Johnson","year":"2012","journal-title":"PLoS One"},{"key":"B46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1152\/physiol.00012.2007","article-title":"Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension","volume":"22","author":"Jonk","year":"2007","journal-title":"Physiol. (Bethesda)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"4735","DOI":"10.7150\/thno.21662","article-title":"The cytotoxic effects of dimethyl sulfoxide in mouse preimplantation embryos: a mechanistic study","volume":"7","author":"Kang","year":"2017","journal-title":"Theranostics"},{"key":"B48","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1158\/2159-8290.CD-14-0650","article-title":"NOTCH decoys that selectively block DLL\/NOTCH or JAG\/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth","volume":"5","author":"Kangsamaksin","year":"2015","journal-title":"Cancer Discov."},{"key":"B49","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.diabres.2013.12.012","article-title":"Microvascular dysfunction as a link between obesity, insulin resistance and hypertension","volume":"103","author":"Karaca","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B50","doi-asserted-by":"publisher","first-page":"e149906","DOI":"10.1172\/JCI149906","article-title":"A mitochondrial unfolded protein response inhibitor suppresses prostate cancer growth in mice via HSP60","volume":"132","author":"Kumar","year":"2022","journal-title":"J. Clin. Invest."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41556-022-01031-6","article-title":"Adherens junctions organize size-selective proteolytic hotspots critical for Notch signalling","volume":"24","author":"Kwak","year":"2022","journal-title":"Nat. Cell Biol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10016-001-0299-x","article-title":"Spatial heterogeneity in VEGF-induced vasodilation: VEGF dilates microvessels but not epicardial and systemic arteries and veins","volume":"17","author":"Laham","year":"2003","journal-title":"Ann. Vasc. Surg."},{"key":"B53","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1200\/JCO.20.01920","article-title":"Camrelizumab plus apatinib in patients with advanced cervical cancer (clap): a multicenter, open-label, single-arm, phase II trial","volume":"38","author":"Lan","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/s41419-021-04113-9","article-title":"Cyclic AMP-binding protein Epac1 acts as a metabolic sensor to promote cardiomyocyte lipotoxicity","volume":"12","author":"Laudette","year":"2021","journal-title":"Cell Death Dis."},{"key":"B55","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.semcancer.2022.09.006","article-title":"Counter regulation of tumor angiogenesis by vascular endothelial growth factor and thrombospondin-1","volume":"86","author":"Lawler","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jtho.2020.10.006","article-title":"Dual EGFR-VEGF pathway inhibition: a promising strategy for patients with EGFR-mutant nsclc","volume":"16","author":"Le","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1152\/physrev.00046.2011","article-title":"Stem cell factor receptor\/c-Kit: from basic science to clinical implications","volume":"92","author":"Lennartsson","year":"2012","journal-title":"Physiol. Rev."},{"key":"B58","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/HYPERTENSIONAHA.122.19427","article-title":"VEGF (vascular endothelial growth factor) inhibition and hypertension: does microvascular rarefaction play a role?","volume":"80","author":"le Noble","year":"2023","journal-title":"Hypertension"},{"key":"B59","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1161\/hc3101.091158","article-title":"Microcirculation in hypertension: a new target for treatment?","volume":"104","author":"Levy","year":"2001","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/CIRCULATIONAHA.107.763730","article-title":"Impaired tissue perfusion: a pathology common to hypertension, obesity, and diabetes mellitus","volume":"118","author":"Levy","year":"2008","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/HJH.0000000000003060","article-title":"Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension","volume":"40","author":"Li","year":"2022","journal-title":"J. Hypertens."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1200\/JCO.2015.63.5995","article-title":"Randomized, double-blind, placebo-controlled phase III trial of apatinib in patients with chemotherapy-refractory advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction","volume":"34","author":"Li","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1186\/s13287-017-0684-1","article-title":"VEGF promotes endothelial progenitor cell differentiation and vascular repair through connexin 43","volume":"8","author":"Li","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"B64","doi-asserted-by":"publisher","first-page":"115987","DOI":"10.1016\/j.biopha.2023.115987","article-title":"Inhibiting the MAPK pathway improves heart failure with preserved ejection fraction induced by salt-sensitive hypertension","volume":"170","author":"Li","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"113921","DOI":"10.1016\/j.bcp.2020.113921","article-title":"Activation of notch 3\/c-MYC\/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus","volume":"175","author":"Li","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"107178","DOI":"10.1016\/j.vph.2023.107178","article-title":"DLL4 promotes partial endothelial-to-mesenchymal transition at atherosclerosis-prone regions of arteries","volume":"150","author":"Li","year":"","journal-title":"Vasc. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13045-023-01439-z","article-title":"The Notch signaling pathway: a potential target for cancer immunotherapy","volume":"16","author":"Li","year":"","journal-title":"J. Hematol. Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.jmb.2006.09.071","article-title":"Quantitative dissection of the Notch:CSL interaction: insights into the Notch-mediated transcriptional switch","volume":"365","author":"Lubman","year":"2007","journal-title":"J. Mol. Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-018-0100-2","article-title":"Notch and interacting signalling pathways in cardiac development, disease, and regeneration","volume":"15","author":"MacGrogan","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B70","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jcmg.2014.12.008","article-title":"Coronary microvascular dysfunction, microvascular angina, and treatment strategies","volume":"8","author":"Marinescu","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"B71","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.chest.2021.09.023","article-title":"Right side of the heart pulmonary circulation unit involvement in left-sided heart failure: diagnostic, prognostic, and therapeutic implications","volume":"161","author":"Marra","year":"2022","journal-title":"Chest"},{"key":"B72","doi-asserted-by":"publisher","first-page":"192","DOI":"10.3181\/00379727-218-44286","article-title":"Ion channels in vascular smooth muscle: alterations in essential hypertension","volume":"218","author":"Martens","year":"1998","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"11085","DOI":"10.1523\/JNEUROSCI.1294-17.2017","article-title":"Dysregulation of the mitochondrial unfolded protein response induces non-apoptotic dopaminergic neurodegeneration in C. elegans models of Parkinson's disease","volume":"37","author":"Martinez","year":"2017","journal-title":"J. Neurosci."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/ehf2.14435","article-title":"Determinants and treatments of heart failure after transcatheter aortic valve implantation: moving up a notch","volume":"10","author":"Matsushita","year":"2023","journal-title":"Esc. Heart Fail"},{"key":"B75","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1097\/HJH.0000000000003503","article-title":"The importance of microvascular inflammation in ageing and age-related diseases: a position paper from the ESH working group on small arteries, section of microvascular inflammation","volume":"41","author":"Mengozzi","year":"2023","journal-title":"J. Hypertens."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cell.2016.04.012","article-title":"Two conserved histone demethylases regulate mitochondrial stress-induced longevity","volume":"165","author":"Merkwirth","year":"2016","journal-title":"Cell"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1002\/ijc.28334","article-title":"Arterial hypertension and cancer","volume":"134","author":"Milan","year":"2014","journal-title":"Int. J. Cancer"},{"key":"B79","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1093\/cvr\/cvz260","article-title":"Selective ETA vs dual ETA\/B receptor blockade for the prevention of sunitinib-induced hypertension and albuminuria in WKY rats","volume":"116","author":"Mirabito Colafella","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/annonc\/mdm550","article-title":"Blood pressure rise following angiogenesis inhibition by bevacizumab. A crucial role for microcirculation","volume":"19","author":"Mourad","year":"2008","journal-title":"Ann. Oncol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s11906-011-0206-y","article-title":"Mechanisms of antiangiogenic-induced arterial hypertension","volume":"13","author":"Mourad","year":"2011","journal-title":"Curr. Hypertens. Rep."},{"key":"B82","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3390\/antiox11020314","article-title":"Pharmacological inhibition of Epac1 averts ferroptosis cell death by preserving mitochondrial integrity","volume":"11","author":"Musheshe","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41440-023-01272-4","article-title":"Denervation or stimulation? Role of sympatho-vagal imbalance in HFpEF with hypertension","volume":"46","author":"Nagai","year":"2023","journal-title":"Hypertens. Res."},{"key":"B84","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cellsig.2009.01.038","article-title":"Forskolin increases angiogenesis through the coordinated cross-talk of PKA-dependent VEGF expression and Epac-mediated PI3K\/Akt\/eNOS signaling","volume":"21","author":"Namkoong","year":"2009","journal-title":"Cell Signal"},{"key":"B85","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1093\/cvr\/cvz021","article-title":"Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury","volume":"115","author":"Neves","year":"2019","journal-title":"Cardiovasc Res."},{"key":"B86","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1161\/HYPERTENSIONAHA.117.10490","article-title":"VEGFR (vascular endothelial growth factor receptor) inhibition induces cardiovascular damage via redox-sensitive processes","volume":"71","author":"Neves","year":"2018","journal-title":"Hypertension"},{"key":"B87","doi-asserted-by":"publisher","first-page":"C1","DOI":"10.1152\/ajpcell.00415.2006","article-title":"Notch signaling in the developing cardiovascular system","volume":"293","author":"Niessen","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1182\/blood-2010-11-319129","article-title":"The Notch1-Dll4 signaling pathway regulates mouse postnatal lymphatic development","volume":"118","author":"Niessen","year":"2011","journal-title":"Blood"},{"key":"B89","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","first-page":"950927","DOI":"10.3389\/fcell.2022.950927","article-title":"Exercise-induced signaling pathways to counteracting cardiac apoptotic processes","volume":"10","author":"Pahlavani","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"B92","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3892\/ijmm.2023.5230","article-title":"Role of the Notch1 signaling pathway in ischemic heart disease (Review)","author":"Peng","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00018-021-03774-1","article-title":"Mitophagy in tumorigenesis and metastasis","volume":"78","author":"Poole","year":"2021","journal-title":"Cell Mol. Life Sci."},{"key":"B94","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/cells10020443","article-title":"Autophagy and mitophagy as essential components of atherosclerosis","volume":"10","author":"Poznyak","year":"2021","journal-title":"Cells"},{"key":"B95","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1161\/CIRCRESAHA.119.315626","article-title":"Role of nitric oxide carried by hemoglobin in cardiovascular physiology: developments on a three-gas respiratory cycle","volume":"126","author":"Premont","year":"2020","journal-title":"Circ. Res."},{"key":"B96","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/14712598.2019.1594770","article-title":"Acute blood pressure elevation associated with biological therapies for cancer: a focus on VEGF signaling pathway inhibitors","volume":"19","author":"Pucci","year":"2019","journal-title":"Expert Opin. Biol. Ther."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0140-6736(23)00961-3","article-title":"Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study","volume":"402","author":"Qin","year":"2023","journal-title":"Lancet"},{"key":"B98","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1074\/jbc.M117.815381","article-title":"The EPAC-Rap1 pathway prevents and reverses cytokine-induced retinal vascular permeability","volume":"293","author":"Ramos","year":"2018","journal-title":"J. Biol. Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"Jama"},{"key":"B100","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.3390\/jcm12154892","article-title":"Microcirculation in hypertension: a therapeutic target to prevent cardiovascular disease?","volume":"12","author":"Rizzoni","year":"2023","journal-title":"J. Clin. Med."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1161\/HYPERTENSIONAHA.110.160481","article-title":"Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors","volume":"56","author":"Robinson","year":"2010","journal-title":"Hypertension"},{"key":"B102","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/pharmaceutics15030917","article-title":"Immunomodulatory activity of the tyrosine kinase inhibitor dasatinib to elicit NK cytotoxicity against cancer, HIV infection and aging","volume":"15","author":"Rodr\u00edguez-Agust\u00edn","year":"2023","journal-title":"Pharmaceutics"},{"key":"B103","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1002\/ehf2.14483","article-title":"Diverging role of epicardial adipose tissue across the entire heart failure spectrum","volume":"10","author":"Rossi","year":"2023","journal-title":"Esc. Heart Fail"},{"key":"B104","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature21695","article-title":"Cytosolic proteostasis through importing of misfolded proteins into mitochondria","volume":"543","author":"Ruan","year":"2017","journal-title":"Nature"},{"key":"B105","doi-asserted-by":"publisher","first-page":"H819","DOI":"10.1152\/ajpheart.00603.2021","article-title":"Mechanisms and clinical implications of endothelium-dependent vasomotor dysfunction in coronary microvasculature","volume":"322","author":"Sabe","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/CMAR.S45193","article-title":"Anti-VEGF agents in metastatic colorectal cancer (mCRC): are they all alike?","volume":"5","author":"Saif","year":"2013","journal-title":"Cancer Manag. Res."},{"key":"B107","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/mt.2008.258","article-title":"Antiangiogenic gene therapy with soluble VEGFR-1, -2, and -3 reduces the growth of solid human ovarian carcinoma in mice","volume":"17","author":"Sallinen","year":"2009","journal-title":"Mol. Ther."},{"key":"B108","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/01.hyp.38.2.238","article-title":"Impaired skin capillary recruitment in essential hypertension is caused by both functional and structural capillary rarefaction","volume":"38","author":"Sern\u00e9","year":"2001","journal-title":"Hypertension"},{"key":"B109","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1080\/14712598.2023.2247987","article-title":"The evolving therapeutic landscape of diabetic retinopathy","volume":"23","author":"Shughoury","year":"2023","journal-title":"Expert Opin. Biol. Ther."},{"key":"B110","doi-asserted-by":"publisher","first-page":"175645","DOI":"10.1016\/j.ejphar.2023.175645","article-title":"Epac as a tractable therapeutic target","volume":"945","author":"Slika","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.hfc.2019.06.007","article-title":"Hypertension and heart failure","volume":"15","author":"Slivnick","year":"2019","journal-title":"Heart Fail Clin."},{"key":"B112","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/cvr\/cvaa002","article-title":"Experimental animal models of coronary microvascular dysfunction","volume":"116","author":"Sorop","year":"2020","journal-title":"Cardiovasc Res."},{"key":"B113","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature25143","article-title":"Enhancing mitochondrial proteostasis reduces amyloid-\u03b2 proteotoxicity","volume":"552","author":"Sorrentino","year":"2017","journal-title":"Nature"},{"key":"B114","doi-asserted-by":"publisher","first-page":"eabo7958","DOI":"10.1126\/sciadv.abo7958","article-title":"JAG1-NOTCH4 mechanosensing drives atherosclerosis","volume":"8","author":"Souilhol","year":"2022","journal-title":"Sci. Adv."},{"key":"B115","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-biophys-101920-082204","article-title":"Biophysics of notch signaling","volume":"50","author":"Sprinzak","year":"2021","journal-title":"Annu. Rev. Biophys."},{"key":"B116","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1158\/1078-0432.CCR-07-5050","article-title":"Hypertension and rarefaction during treatment with telatinib, a small molecule angiogenesis inhibitor","volume":"14","author":"Steeghs","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"B117","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1161\/HYPERTENSIONAHA.111.181107","article-title":"Early life microcirculation and the development of hypertension","volume":"58","author":"Struijker-Boudier","year":"2011","journal-title":"Hypertension"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.3390\/nu13051731","article-title":"Is there association between altered adrenergic system activity and microvascular endothelial dysfunction induced by a 7-day high salt intake in young healthy individuals","volume":"13","author":"Stupin","year":"2021","journal-title":"Nutrients"},{"key":"B119","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1111\/cas.15674","article-title":"Notch pathway regulates osimertinib drug-tolerant persistence in EGFR-mutated non-small-cell lung cancer","volume":"114","author":"Takahashi","year":"2023","journal-title":"Cancer Sci."},{"key":"B120","doi-asserted-by":"publisher","first-page":"112726","DOI":"10.1016\/j.biopha.2022.112726","article-title":"Epac, a positive or negative signaling molecule in cardiovascular diseases","volume":"148","author":"Tan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"B121","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11906-015-0543-3","article-title":"Capillary rarefaction as an index for the microvascular assessment of hypertensive patients","volume":"17","author":"Triantafyllou","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"key":"B122","doi-asserted-by":"publisher","first-page":"e29863","DOI":"10.1371\/journal.pone.0029863","article-title":"Low-dosage inhibition of Dll4 signaling promotes wound healing by inducing functional neo-angiogenesis","volume":"7","author":"Trindade","year":"2012","journal-title":"PLoS One"},{"key":"B123","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/cvr\/cvx103","article-title":"Enhanced endothelin-1\/Rho-kinase signalling and coronary microvascular dysfunction in hypertensive myocardial hypertrophy","volume":"113","author":"Tsai","year":"2017","journal-title":"Cardiovasc Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/jth.14225","article-title":"Acquired platelet antagonism: off-target antiplatelet effects of malignancy treatment with tyrosine kinase inhibitors","volume":"16","author":"Tullemans","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"B125","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0002-9440(10)63290-7","article-title":"Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system","volume":"165","author":"Ungvari","year":"2004","journal-title":"Am. J. Pathol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41581-021-00430-6","article-title":"Hypertension-induced cognitive impairment: from pathophysiology to public health","volume":"17","author":"Ungvari","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.3390\/jcm9092880","article-title":"Coronary microvascular dysfunction","volume":"9","author":"Vancheri","year":"2020","journal-title":"J. Clin. Med."},{"key":"B128","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.2741\/3377","article-title":"Tyrosine kinase inhibitors of VEGF receptors: clinical issues and remaining questions","volume":"14","author":"van Cruijsen","year":"2009","journal-title":"Front. Biosci. Landmark Ed."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.121.318051","article-title":"Hypertension and prohypertensive antineoplastic therapies in cancer patients","volume":"128","author":"van Dorst","year":"2021","journal-title":"Circ. Res."},{"key":"B130","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/S1470-2045(22)00128-0","article-title":"Nivolumab, nivolumab-ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open-label, non-comparative, randomised, phase 2 trial","volume":"23","author":"Vano","year":"2022","journal-title":"Lancet Oncol."},{"key":"B131","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/j.ijbiomac.2022.09.129","article-title":"A concise review of VEGF, PDGF, FGF, Notch, angiopoietin, and HGF signalling in tumor angiogenesis with a focus on alternative approaches and future directions","volume":"221","author":"Vimalraj","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1161\/HYPERTENSIONAHA.120.16065","article-title":"Reduced Notch1 cleavage promotes the development of pulmonary hypertension","volume":"79","author":"Wang","year":"","journal-title":"Hypertension"},{"key":"B134","doi-asserted-by":"publisher","first-page":"873829","DOI":"10.3389\/fcvm.2022.873829","article-title":"Research on the mechanism and prevention of hypertension caused by apatinib through the RhoA\/ROCK signaling pathway in a mouse model of gastric cancer","volume":"9","author":"Wang","year":"","journal-title":"Front. Cardiovasc Med."},{"key":"B135","doi-asserted-by":"publisher","first-page":"894","DOI":"10.21037\/atm-21-2133","article-title":"A narrative review on the interaction between genes and the treatment of hypertension and breast cancer","volume":"9","author":"Wang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"B136","doi-asserted-by":"publisher","first-page":"5367","DOI":"10.1007\/s12010-022-04020-5","article-title":"Apatinib through activating the RhoA\/ROCK signaling pathway to cause dysfunction of vascular smooth muscle cells","volume":"194","author":"Wang","year":"","journal-title":"Appl. Biochem. Biotechnol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/s0014-5793(97)01481-6","article-title":"Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42\/p44 mitogen-activated protein kinase","volume":"420","author":"Wheeler-Jones","year":"1997","journal-title":"FEBS Lett."},{"key":"B138","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ame2.12334","article-title":"Biology and function of pericytes in the vascular microcirculation","volume":"6","author":"Wu","year":"2023","journal-title":"Anim. Model Exp. Med."},{"key":"B139","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijcard.2022.05.025","article-title":"PINK1\/Parkin-mediated mitophagy in cardiovascular disease: from pathogenesis to novel therapy","volume":"361","author":"Wu","year":"2022","journal-title":"Int. J. Cardiol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1083\/jcb.202201071","article-title":"The UPRmt preserves mitochondrial import to extend lifespan","volume":"221","author":"Xin","year":"2022","journal-title":"J. Cell Biol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1158\/1078-0432.CCR-20-2571","article-title":"Camrelizumab in combination with apatinib in patients with advanced hepatocellular carcinoma (rescue): a nonrandomized, open-label, phase II trial","volume":"27","author":"Xu","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","article-title":"Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-\u03b21","volume":"37","author":"Yang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.3390\/medicina59122149","article-title":"Coronary microvascular dysfunction and hypertension: a bond more important than we think","volume":"59","author":"Zdravkovic","year":"2023","journal-title":"Med. Kaunas."},{"key":"B144","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.celrep.2018.12.048","article-title":"Endocardial notch signaling promotes cardiomyocyte proliferation in the regenerating zebrafish heart through wnt pathway antagonism","volume":"26","author":"Zhao","year":"2019","journal-title":"Cell Rep."},{"key":"B145","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/10641963.2017.1288736","article-title":"Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: evidence from observational studies","volume":"40","author":"Zhao","year":"2018","journal-title":"Clin. Exp. Hypertens."},{"key":"B146","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Target Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1346905\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:25:07Z","timestamp":1707488707000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1346905\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":146,"alternative-id":["10.3389\/fphar.2024.1346905"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1346905","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"article-number":"1346905"}}